Marksans Pharma - Quaterly Results

14 Nov 2022 Evaluate
The Total revenue for the quarter ended September 2022 of  Rs. 1702.59 millions remain, more or less, the same.A good growth in profit of 45.77% reported to Rs. 402.29  millions over Rs. 275.97 millions of corresponding previous quarter.Operating profit for the quarter ended September 2022 rose to 548.05 millions as compared to 425.27 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1702.59 1688.53 0.83 3294.11 3160.74 4.22 6582.89 5995.48 9.80
Other Income 210.34 85.98 144.64 404.66 225.38 79.55 422.51 311.56 35.61
PBIDT 548.05 425.27 28.87 858.44 815.64 5.25 1559.66 1448.68 7.66
Interest 12.91 12.02 7.40 21.08 18.32 15.07 37.95 53.45 -29.00
PBDT 535.14 413.25 29.50 837.36 797.32 5.02 1521.71 1395.23 9.07
Depreciation 45.30 43.04 5.25 90.48 85.33 6.04 176.63 151.93 16.26
PBT 489.84 370.21 32.31 746.88 711.99 4.90 1345.08 1243.30 8.19
TAX 87.55 94.24 -7.10 152.53 146.96 3.79 305.20 259.49 17.62
Deferred Tax 1.88 18.60 -89.89 0.94 15.08 -93.77 5.04 -22.39 -122.51
PAT 402.29 275.97 45.77 594.35 565.03 5.19 1039.88 983.81 5.70
Equity 404.23 409.31 -1.24 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 32.19 25.19 27.81 26.06 25.81 0.99 23.69 24.16 -1.95

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×